The purpose of this study is to evaluate the steady-state kinetics of delavirdine in HIV-positive patients after escalating and non-escalating doses. In doing so, these studies will be of great value in developing a safe and effective dose of delavirdine, and in helping to increase the survival time and quality of life for those individuals with AIDS.
Showing the most recent 10 out of 1380 publications